VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease - A Randomized-Controlled Multicenter Study
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This prospective, randomized-controlled multicenter study investigates whether virtual reality-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• High-grade aortic valve stenosis
• Indication for elective transfemoral transcatheter aortic valve implantation under analgesia (TAVI)
• Existing heart center decision
• Age ≥ 18 years
• Signed informed consent form
Locations
Other Locations
Germany
Universitätsklinikum Köln, Klinik III für Innere Medizin, Herzzentrum, Kerpener Straße 62
RECRUITING
Cologne
Universitätsklinikum Düsseldorf, Klinik für Kardiologie, Pneumologie & Angiologie
RECRUITING
Düsseldorf
Contact Information
Primary
Christian Jung, Prof MD PhD
christian.jung@med.uni-duesseldorf.de
+49 211 81
Backup
Raphael Bruno, MD
raphael.bruno@med.uni-duesseldorf.de
+49 211 81
Time Frame
Start Date: 2022-10-05
Estimated Completion Date: 2027-02-28
Participants
Target number of participants: 300
Treatments
Experimental: Intervention Arm
Patients in the intervention arm receive on the day before the implantation of the artificial aortic valve, a virtual reality assisted information. On the day of the implantation the patients are informed about the process via virtual reality assisted information.
No_intervention: Control Arm
Patients in the control arm receive no virtual reality assisted information.
Related Therapeutic Areas
Sponsors
Collaborators: Edwards Lifesciences
Leads: Heinrich-Heine University, Duesseldorf